Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of diabetes
3.2.1.2 Technological advancements in insulin pumps
3.2.1.3 Favourable device insurance and reimbursement policies
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of insulin pumps
3.2.2.2 Stringent government regulations
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
3.6.1 Supplier power
3.6.2 Buyer power
3.6.3 Threat of new entrants
3.6.4 Threat of substitutes
3.6.5 Industry rivalry
3.7 PESTEL analysis
3.8 Reimbursement scenario
3.9 Future market trends
3.10 Gap analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates And Forecast, By Product, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Devices
5.2.1 Tubed/tethered
5.2.2 Tubeless
5.3 Accessories
5.3.1 Battery
5.3.2 Insulin reservoir or cartridges
5.3.3 Insulin set insertion devices
Chapter 6 Market Estimates And Forecast, By End-Use, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Home care
6.3 Hospitals & clinics
6.4 Other end-users
Chapter 7 Market Estimates And Forecast, By Region, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Italy
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.4.6 Rest of Asia Pacific
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.5.4 Rest of Latin America
7.6 Middle East and Africa
7.6.1 Saudi Arabia
7.6.2 South Africa
7.6.3 UAE
7.6.4 Rest of Middle East and Africa
Chapter 8 Company Profiles
8.1 Debiotech S.A.
8.2 F. Hoffmann La Roche AG
8.3 Insulet Corporation
8.4 Lenomed Medical
8.5 Medtronic plc
8.6 MicroPort Scientific Corporation
8.7 Nipro Corporation
8.8 Tandem Diabetic Care Inc.
8.9 Terumo Corporation
8.10 ViCentra B.V.
8.11 Ypsomed
